These results suggest that TOPK may promote metastasis by regulating IL19 expression.” These findings align with clinical observations that CAF density correlates with cSCC aggressiveness, but our work identifies TOPK as the molecular linchpin enabling this collaboration. The gene discussed is IL19; the disease is skin squamous cell carcinoma.